About I5 Clinical Research Private Limited
Data last updated:
I5 Clinical Research Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 November 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U73100TN2009PTC073642. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Yogesh Sharma and Thanigai Dakshnamoorthy Arasu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.153 6th Street Krishna Nagar Tambaram West, Chennai, Tamil Nadu, India – 600045.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website i5clinicalresearch.com.
Company details
Contact details
I5 Clinical Research Private Limited's registered office is in Chennai, Tamil Nadu. Its website is i5clinicalresearch.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.153 6th Street Krishna Nagar Tambaram West, Chennai, Tamil Nadu, India – 600045
- IndustryPharma, Pharma Contract R&D
To see the full contact details of I5 Clinical Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of I5 Clinical Research Private Limited
FY 2025 filings availableI5 Clinical Research Private Limited reported revenue of ₹382 (down 95% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 83% over five years, including a 95% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹382 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of I5 Clinical Research Private Limited, buy the company report.
Board of directors of I5 Clinical Research Private Limited
I5 Clinical Research has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogesh Sharma | Director | 29 Jul 2017 | 9 Years 3 Months | Current |
| Thanigai Dakshnamoorthy Arasu Also directs: Medlix Hospitals and Healthcare LLP, Tavagraha Health Solutions Private Limited, Medlix Health Solutions Private Limited and 1 more | Director | 01 Nov 2011 | 15 Years 0 Months | Current |
Auditor
I5 Clinical Research Private Limited is audited by VKJD & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VKJD & ASSOCIATES | FY 2022 | 128985W |
Shareholding
The shareholding of I5 Clinical Research Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of I5 Clinical Research Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Feb 2013 | 10412555 | Hdfc Bank Limited | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving I5 Clinical Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for I5 Clinical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
I5 Clinical Research has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of I5 Clinical Research Private Limited, buy the company report.
Recent activity
I5 Clinical Research Private Limited has 7 board changes on record since 2011: 2 appointments and 5 cessations. The latest: Yogesh Sharma ceased to be Additional Director on 30 Sep 2017.
Frequently asked questions
I5 Clinical Research is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 23 November 2009 (17+ years old) and is registered under CIN U73100TN2009PTC073642.
I5 Clinical Research has 2 current directors:
- Yogesh Sharma - Director
- Thanigai Dakshnamoorthy Arasu - Director
The latest financial statements of I5 Clinical Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. I5 Clinical Research has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of I5 Clinical Research is U73100TN2009PTC073642. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I5 Clinical Research was incorporated on 23 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chennai.
Yogesh Sharma ceased to be Additional Director on 30 Sep 2017. Annakutty ceased to be Director on 14 Sep 2017. Gowri Shankar Palanisami ceased to be Director on 14 Sep 2017. I5 Clinical Research has 7 board changes on record in total.
I5 Clinical Research can be reached through the website i5clinicalresearch.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of I5 Clinical Research is at No.153 6th Street Krishna Nagar Tambaram West, Chennai, Tamil Nadu, India – 600045.
I5 Clinical Research operates in the pharma industry, in the pharma contract r and d segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
